Xu Jianfen, Zhu Jinnuo, Mei Changqing, Liu Xiaopeng, Gong Zhiming, Huang Jiansheng, Chai Hui
School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, P.R. China.
Department of Clinical Laboratory, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, P.R. China.
J Microbiol Biotechnol. 2025 Jul 14;35:e2412081. doi: 10.4014/jmb.2412.12081.
The New Delhi metallo--lactamase (NDM; EC 3.5.2.6) poses significant challenges to carbapenem treatment, yet the regulatory mechanisms governing gene expression remain poorly understood. In this study, we identified a highly conserved 110 bp sequence located upstream of the gene by comparative analysis of 109 clinical isolates and 2,706 nucleotide sequences from the NCBI database. This conserved sequence was characterized in all available NDM variants spanning 80 bacterial species. Bioinformatics analysis revealed a core promoter (PNDM) and two transcription factor binding sites (ArcA and ArgR2) within the sequence. Mutations of the PNDM promoter significantly reduced expression (mRNA and protein) by more than 90% ( < 0.01) and completely restored carbapenem susceptibility. Electrophoretic mobility shift assays (EMSA) confirmed the specific binding of ArcA and ArgR2 proteins to their predicted sites. Mutations in the ArcA and ArgR2 binding sites decreased protein production with less pronounced effects compared to PNDM promoter mutations, resulting in 24% and 32.7% reductions, respectively. The findings highlight the critical role of the highly conserved 110 bp sequence in regulating expression, offering potential targets for novel therapeutic strategies.
新德里金属β-内酰胺酶(NDM;EC 3.5.2.6)给碳青霉烯类药物治疗带来了重大挑战,然而,关于其基因表达的调控机制仍知之甚少。在本研究中,我们通过对109株临床分离株以及来自NCBI数据库的2706个核苷酸序列进行比较分析,在该基因上游鉴定出一段高度保守的110 bp序列。在涵盖80种细菌的所有已知NDM变体中均发现了这一保守序列。生物信息学分析揭示了该序列内的一个核心启动子(PNDM)以及两个转录因子结合位点(ArcA和ArgR2)。PNDM启动子的突变使表达(mRNA和蛋白质)显著降低了90%以上(P<0.01),并完全恢复了对碳青霉烯类药物的敏感性。电泳迁移率变动分析(EMSA)证实了ArcA和ArgR2蛋白与其预测位点的特异性结合。与PNDM启动子突变相比,ArcA和ArgR2结合位点的突变对蛋白质产生的影响较小,分别导致蛋白质产量降低了24%和32.7%。这些发现突出了高度保守的110 bp序列在调节NDM表达中的关键作用,为新型治疗策略提供了潜在靶点。